PPOX Gene Porphyria Variegata Genetic Test in UAE | 2,800 AED

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing and strict internal quality controls.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic post-test clinical guidance in result interpretation provided by a DHA-licensed Consultant Medical Geneticist.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The PPOX Gene Porphyria Variegata NGS test detects pathogenic variants in the PPOX gene using Next Generation Sequencing. This comprehensive analysis covers all coding exons and flanking intronic regions, ensuring greater than 99% diagnostic yield for symptomatic patients and at-risk family members. Variegate porphyria is a hereditary metabolic disorder that can cause acute neurovisceral attacks and photosensitive skin lesions; early molecular confirmation is essential for guiding photoprotection, trigger avoidance, and family screening.

Feature	Our Test – NGS Comprehensive	Closest Alternative – Sanger Sequencing
Precision	Full gene coverage, including deep intronic regions and copy number variants	Limited to targeted amplicons; may miss large deletions or duplications
Methodology	Next Generation Sequencing (NGS) with bioinformatic variant filtration	Sanger sequencing of individual exons (low throughput)
Turnaround Time	3–4 Weeks	6–8 Weeks (sequential processing)

Physician Insight & Safety Protocols

"Genetic confirmation of variegate porphyria through PPOX sequencing provides a clear molecular diagnosis that can significantly alter clinical management. A positive result guides photoprotection strategies and avoids porphyrinogenic drugs, while a negative result offers reassurance. Post-test counselling remains essential to address inheritance patterns and family screening."

— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403

Medication Advisory

Do not discontinue or alter any prescribed medication without consulting your treating physician. Genetic test results should be integrated with a complete clinical evaluation before any changes to your treatment regimen are considered.

Safety Exclusion Criteria & Emergency Red Flags

Exclusion Criteria: No specific contraindications for standard venipuncture. The test can be performed on stable patients of any age, including minors with legal guardian consent as per UAE regulations.
Emergency Red Flags: If you experience sudden severe abdominal pain, vomiting, confusion, seizures, or muscle weakness after sample collection (unrelated to the draw procedure), call 998 immediately. These signs may indicate an acute porphyria attack and require urgent medical evaluation.

Patient FAQ & Clinical Guidance

1. What is the clinical utility of the PPOX NGS test?

This test identifies pathogenic variants in the PPOX gene with 99% diagnostic yield, enabling definitive diagnosis of variegate porphyria. It differentiates variegate porphyria from other acute porphyrias and guides precision management, including photoprotection, trigger avoidance, and family screening. Molecular confirmation is considered the gold standard for this condition.

2. How long does it take to get results?

Results are typically available within 3 to 4 weeks from sample receipt. Comprehensive NGS analysis and variant interpretation require meticulous laboratory procedures including bioinformatic filtering and clinical classification. Expedited reporting is not available due to the multi-step validation process mandated by DHA guidelines.

3. Does this test require a genetic counselling session?

Yes, pre-test genetic counselling is mandatory to explain possible outcomes, inheritance patterns, and implications for family members. We provide telephonic post-test guidance to support informed decision-making and psychological preparedness. This process aligns with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

UAE Regulatory & Data Privacy Adherence

Your data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing safety and patient consent procedures comply with Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE is fully licensed by the Dubai Health Authority (DHA) and adheres to the highest standards of laboratory practice, data confidentiality, and ethical oversight.

Clinical & Logistical Metadata

Test Name	PPOX Gene Porphyria Variegata Genetic Test (NGS)
Price (AED)	2,800 AED
Turnaround Time	3–4 Weeks
Sample Type / Matrix	Whole Blood (Peripheral) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection
Methodology Used	Next Generation Sequencing (NGS) with Bioinformatic Variant Filtration
ICD-10-CM Code	E80.2
LOINC Code	58114-3
DHA Facility License & Laboratory Address	DHA Facility License Number: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE